Evaxion Biotech Announces FY 2023 Financial Results

Wednesday, 27 March 2024, 17:49

Evaxion Biotech has released its FY 2023 financial results, revealing a GAAP EPS of -$0.81 and disclosing a decrease in cash and equivalents to $5.6 million. The financial performance of Evaxion Biotech in the reported year indicates challenges faced by the company in maintaining profitability and liquidity. The negative EPS and reduced cash reserves signal potential hurdles that Evaxion Biotech needs to overcome to ensure financial stability and growth.

LivaRava Finance Meta Image — Evaxion Biotech Announces FY 2023 Financial Results

Evaxion Biotech Financial Results for FY 2023

Evaxion Biotech announced its financial results for FY 2023, reporting a GAAP EPS of -$0.81. The company also noted a decrease in cash and equivalents to $5.6 million.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.

Evaxion Biotech Financial Results for FY 2023

Related posts